“The compound SR-17018 is the initial biased agonist on the mu opioid receptor that does not bring about tolerance with Persistent use,” says Stahl, a senior staff scientist in the Bohn lab. “This is the attractive element for prospective use inside the context of chronic, severe suffering.”Don’t pass up a eureka minute! Get the most rece